Photoactivable drugs are activated when irradiated by a beam of light—via an optical fiber—thus generating a controlled and local therapeutic effect on target tissues. Now, a scientific team has pioneered a new breakthrough in the field of photopharmacology with the design of the first wireless device capable of remotely activating a photoactivable drug and causing it to have therapeutic effects on specific organs.

Scientists have engineered a monoclonal antibody that can protect mice from a lethal dose of influenza A, a new study shows. The new molecule combines the specificity of a mature flu fighter with the broad binding capacity of a more general immune system defender.

University of Cincinnati engineers have created a new device to help doctors diagnose depression and anxiety.

Innovative platform streamlines sample-to-result diagnostics, offering scalable, multiplexed solutions for global clinical laboratories.

Breakthrough intravascular lithotripsy device to begin first-in-human trials for treatment of calcified coronary artery disease